Stock info Abivax | Filter  Basic-Info

Abivax

The past year was a relatively good year for Abivax investors

Over the last 12 months, that were loss-making period for the investors in Abivax, the stock lost around 56 percent. Over the period 2011-2016 the stock lost a modest 0 percent.

The global biotech companies gained around 59 percent over the period 2006-2016. Over the past 5 years the sector is 70 percent higher.

Over the past 5 years the French company paid out dividends.

Abivax financed with a quite low debt position

As per the end of 2015 the French company's balance sheet equaled 0 million euros. The total debt of the biotech company was at the end of 2015 0 million euros, which equals around percent of the total balance sheet.

All the company's financial reports are available here. More information about Abivax can be found it's website. .